11p15.4 microduplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:300305Q92.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

11p15.4 microduplication syndrome is a very rare genetic condition caused by a small extra copy (duplication) of genetic material on the short arm of chromosome 11, specifically at the region labeled 15.4. This means that instead of having two copies of certain genes in this area, a person has three copies. This extra genetic material can disrupt normal development and body function. The syndrome can affect multiple body systems. Common features may include developmental delay, intellectual disability, speech and language difficulties, and distinctive facial features. Some individuals may also experience behavioral challenges, growth problems, or other birth differences. The severity of symptoms can vary widely from person to person, even within the same family, depending on the exact size of the duplicated region and which genes are involved. Because this condition is so rare, there is no specific cure or targeted treatment. Management focuses on addressing each individual's symptoms through supportive therapies such as speech therapy, occupational therapy, physical therapy, and special education services. Regular follow-up with a team of specialists helps ensure that emerging issues are caught and managed early. Research into this condition is still ongoing, and our understanding continues to grow as more cases are identified through advanced genetic testing.

Also known as:

Key symptoms:

Developmental delayIntellectual disabilitySpeech and language delaysDistinctive facial featuresBehavioral difficultiesLearning difficultiesLow muscle tone (floppiness)Growth delays or short statureFeeding difficulties in infancyMotor skill delaysAttention problemsAnxiety or social difficulties

Clinical phenotype terms (18)— hover any for plain English
Increased overbiteHP:0011094Appendicular hypotoniaHP:0012389
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 11p15.4 microduplication syndrome.

View clinical trials →

No actively recruiting trials found for 11p15.4 microduplication syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 11p15.4 microduplication syndrome community →

No specialists are currently listed for 11p15.4 microduplication syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 11p15.4 microduplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 11p15.4 microduplication syndromeForum →

No community posts yet. Be the first to share your experience with 11p15.4 microduplication syndrome.

Start the conversation →

Latest news about 11p15.4 microduplication syndrome

No recent news articles for 11p15.4 microduplication syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact size and location of my child's duplication, and which genes are involved?,Was this duplication inherited from a parent or did it happen for the first time in my child?,What developmental milestones should I watch for, and when should I be concerned?,What therapies do you recommend starting right away?,Are there any medical complications I should be screened for, such as seizures or heart problems?,How will this condition affect my child's learning, and what school supports should I request?,Should other family members be tested for this duplication?

Common questions about 11p15.4 microduplication syndrome

What is 11p15.4 microduplication syndrome?

11p15.4 microduplication syndrome is a very rare genetic condition caused by a small extra copy (duplication) of genetic material on the short arm of chromosome 11, specifically at the region labeled 15.4. This means that instead of having two copies of certain genes in this area, a person has three copies. This extra genetic material can disrupt normal development and body function. The syndrome can affect multiple body systems. Common features may include developmental delay, intellectual disability, speech and language difficulties, and distinctive facial features. Some individuals may als

At what age does 11p15.4 microduplication syndrome typically begin?

Typical onset of 11p15.4 microduplication syndrome is infantile. Age of onset can vary across affected individuals.